Antimicrobial and Antifungal Properties of Zerumbone

Zerumbone and crude Zingiber zerumbet extracts have been tested against a genuinely wide range of bacteria and fungi — stomach bacteria, acne bacteria, oral biofilms, drug-resistant yeast. This page works through that literature, and then turns to the question the plant's own common name invites: does any of it actually support the "shampoo" claim, or is the antimicrobial chemistry real but simply never pointed at the scalp?

Table of Contents

  1. An In-Vitro Literature, Not a Treatment Literature
  2. Helicobacter pylori Urease Inhibition
  3. Acne-Causing and Oral/Endodontic Bacteria
  4. Candida Biofilms, Including Fluconazole-Resistant Strains
  5. Dermatophytes and Skin-Infection Formulations
  6. Food-Preservative and Antifungal Applications
  7. Does Any of This Support the "Shampoo" Claim?
  8. What Approved Antimicrobial Drugs Tell Us About the Ceiling
  9. Cautions
  10. Key Research Papers
  11. Connections

An In-Vitro Literature, Not a Treatment Literature

Every study on this page is a laboratory assay — zerumbone or a rhizome extract applied directly to bacteria, fungi, or a biofilm growing in a dish, with growth inhibition, minimum inhibitory concentration, or biofilm disruption as the measured outcome. None of it is an animal infection model, and none of it is a human trial. That distinction matters more here than almost anywhere else on this site: a compound that inhibits a bacterium or fungus in a petri dish has cleared the lowest bar in antimicrobial drug development, not a high one. Reaching an infected tissue at an effective, non-toxic concentration, and clearing an actual infection in a living organism, are separate and much harder problems that this literature has not yet addressed for zerumbone.

Back to Table of Contents

Helicobacter pylori Urease Inhibition

A 2021 study found zerumbone inhibits the urease enzyme of Helicobacter pylori, the bacterium responsible for most peptic ulcers and a major stomach-cancer risk factor. Urease is central to how H. pylori survives stomach acid — it converts urea to ammonia, locally neutralising acid around the bacterium so it can colonise the stomach lining. An isolated enzyme-inhibition assay like this one is a narrower finding than it might sound: it shows zerumbone can block the purified enzyme in a test tube, not that it clears an actual H. pylori infection in a stomach, where the bacterium is protected by mucus, biofilm and access issues an isolated-enzyme assay does not model.

This finding sits in an awkward position relative to the main Wild Ginger page's digestive-use discussion: the flagship paper claiming zerumbone had broader antisecretory, gastroprotective and anti-H. pylori whole-organism activity — a much stronger and more clinically relevant claim than isolated urease inhibition — was formally retracted in 2023 for data-integrity concerns. The full story, and what does and does not survive it, is covered on the Digestive, Liver and Metabolic Health page.

Back to Table of Contents

Acne-Causing and Oral/Endodontic Bacteria

A 2024 study tested Zingiber zerumbet extract (alongside galangal, another Zingiberaceae rhizome) against acne-causing bacteria specifically, alongside cytotoxicity screening and phytochemical analysis — a skin-relevant application, though tested as a topical/dish assay rather than in an actual acne patient.

A separate 2023 study screened Zingiber zerumbet's antioxidant activity and phytochemistry alongside antimicrobial efficacy against selective endodontic bacteria — the bacteria implicated in root-canal infections. A 2025 study extracted lempoyang using a "subcritical water" technique (pressurised hot water, a green-chemistry extraction method) and confirmed antibacterial potential alongside a phytochemical composition analysis, adding a second, methodologically distinct confirmation of general antibacterial activity from the same plant. An older, foundational 2011 study established general antimicrobial activity of the rhizome extract, without narrowing to a specific bacterial target — useful as an early baseline for the more targeted studies that followed.

Back to Table of Contents

Candida Biofilms, Including Fluconazole-Resistant Strains

The single largest and most methodologically interesting cluster of antimicrobial studies concerns Candida albicans — the yeast responsible for oral thrush, vaginal yeast infections, and, in the specific dental-research context most of these papers come from, denture-related and biofilm-associated oral infections.

Read as a set, this cluster is a real and reasonably independent body of work — two separate research groups (Korean and Brazilian), consistent findings, and a specific, clinically-motivated focus on drug-resistant strains rather than only easy, drug-susceptible ones. It remains entirely in-vitro biofilm-on-plastic or biofilm-in-a-dish work; no animal or human oral/vaginal candidiasis model has been tested.

Back to Table of Contents

Dermatophytes and Skin-Infection Formulations

A 2017 study isolated zerumbone from the rhizome and confirmed both antidermatophytic activity (against the fungi responsible for ringworm, athlete's foot and similar skin infections) and protease-inhibiting activity, a mechanism some antifungal strategies exploit since proteases help fungi invade tissue.

A 2022 formulation study went a step further than a simple activity assay: it developed and evaluated ethosomes (a lipid-vesicle drug-delivery system designed to carry compounds through the skin's outer barrier) loaded with Zingiber zerumbet rhizome extract, specifically targeting antifungal delivery to deep skin layers. This is meaningfully more advanced than most of the literature on this page — it is at least attempting to solve the delivery problem, rather than only demonstrating activity in a dish — though it remains a formulation and delivery study, not a treated-infection study in an animal or person.

Back to Table of Contents

Food-Preservative and Antifungal Applications

A 2021 study developed a Zingiber zerumbet essential-oil-based chitosan nanoemulsion as a green food preservative, tested against fungal contamination and aflatoxin B1 — a highly potent, carcinogenic mycotoxin produced by Aspergillus mould species that contaminates stored grain and nuts. This is a food-safety application rather than a medical one: the goal is preventing mould growth (and the toxin it produces) in stored food, not treating an infection in a person, but it is a genuine practical use case with its own, separate body of supporting evidence.

Back to Table of Contents

Does Any of This Support the "Shampoo" Claim?

The main Wild Ginger page is direct about the plant's namesake use: the mature flower cone's mucilage was used as a hair rinse across the Pacific and Southeast Asia, the effect is physical (a slippery polysaccharide gel that coats and lubricates the hair shaft), and claims that it treats dandruff, stimulates growth or reverses hair loss are explicitly not supported by clinical evidence. This page's antimicrobial and antifungal literature is the most tempting place a reader might look for a loophole in that conclusion — "zerumbone kills fungi, dandruff is caused by a fungus, therefore …" — so it is worth checking that reasoning directly rather than leaving it implied.

It does not hold up, and the reason is precise. Dandruff and seborrheic dermatitis are driven predominantly by Malassezia species — a distinct genus of yeast from Candida, with different cell biology and different susceptibility patterns. A live, targeted search of the literature for zerumbone or Zingiber zerumbet combined with hair, scalp, dandruff or alopecia returns zero results. Every antifungal finding on this page tested Candida albicans (oral, denture and biofilm contexts) or general dermatophytes (ringworm-type skin fungi) — never Malassezia, never a scalp model, never a dandruff or hair-loss endpoint of any kind.

This is a specific instance of a general trap this site's evidence doctrine names directly: an antifungal finding against one organism, in one tissue context, does not transfer to a different organism in a different tissue context without being tested there. It would be exactly the same error as citing a lung antifungal result as evidence for a foot infection — the genus is different, the biofilm environment is different, and nothing about testing zerumbone against Candida on acrylic resin tells you what it would do against Malassezia on a human scalp. The honest summary: shampoo ginger's antimicrobial chemistry is real, and separately, its use as a hair rinse is real and traditional — but nobody has ever connected the two. The traditional use is supported by physics (mucilage lubrication), not by any tested antifungal or scalp-health mechanism.

Back to Table of Contents

What Approved Antimicrobial Drugs Tell Us About the Ceiling

It is worth being concrete about what an isolated in-vitro finding, however real, is up against. H. pylori eradication in clinical practice is never attempted with a urease inhibitor alone — every approved regimen combines a proton-pump inhibitor with two or more antibiotics given together, precisely because single-agent approaches (including approved urease inhibitors like acetohydroxamic acid, used in a completely different context for struvite kidney stones) do not reliably clear an established infection. A urease-inhibition finding in a test tube, however real, is not on a path to becoming a stomach-infection treatment by itself.

Similarly, fluconazole itself remains the first-line approved azole antifungal for candidiasis, and the entire reason the Brazilian research group's work specifically targets fluconazole-resistant strains is that resistance to the approved standard is an increasingly real clinical problem. That framing is honest about the size of the unmet need, but it does not mean zerumbone is close to filling it — every one of those studies pairs zerumbone with an existing treatment (photodynamic therapy) or tests it in an artificial biofilm system, not as a standalone replacement therapy that has cleared any stage of drug development beyond in-vitro screening.

Back to Table of Contents

Cautions

Back to Table of Contents

Key Research Papers

  1. Woo HJ, Yang JY, Lee P, Kim JB, Kim SH (2021). Zerumbone Inhibits Helicobacter pylori Urease Activity. Molecules, 26(9). — PubMed
  2. Na Nongkhai T, Maddocks SE, Phosri S, et al. (2024). In Vitro Cytotoxicity and Antimicrobial Activity against Acne-Causing Bacteria and Phytochemical Analysis of Galangal (Alpinia galanga) and Bitter Ginger (Zingiber zerumbet) Extracts. International Journal of Molecular Sciences, 25(20). — PubMed
  3. Assiry AA, Ahmed N, Almuaddi A, et al. (2023). The antioxidant activity, preliminary phytochemical screening of Zingiber zerumbet and antimicrobial efficacy against selective endodontic bacteria. Food Science & Nutrition, 11(8):4853–4860. — PubMed
  4. Ahmad N, Nordin MFM, Mokhtar N, et al. (2025). Antibacterial Potential and Phytochemical Composition in Subcritical Water Extraction of Lempoyang (Zingiber zerumbet). Tropical Life Sciences Research, 36(1):163–186. — PubMed
  5. Jyothilakshmi M, Jyothis M, Narayanan GN, Latha MS (2017). Antidermatophytic and Protease-inhibiting Activities of Zerumbone: A Natural Sesquiterpene from the Rhizome of Zingiber zerumbet. Pharmacognosy Magazine, 13(49):2–6. — PubMed
  6. Shin DS, Eom YB (2019). Zerumbone inhibits Candida albicans biofilm formation and hyphal growth. Canadian Journal of Microbiology, 65(10):713–721. — PubMed
  7. Shin DS, Eom YB (2019). Efficacy of zerumbone against dual-species biofilms of Candida albicans and Staphylococcus aureus. Microbial Pathogenesis, 137:103768. — PubMed
  8. Abreu-Pereira CA, Gorayb-Pereira AL, Menezes Noveletto JV, Jordão CC, Pavarina AC (2023). Zerumbone Disturbs the Extracellular Matrix of Fluconazole-Resistant Candida albicans Biofilms. Journal of Fungi, 9(5). — PubMed
  9. Abreu-Pereira CA, Gorayb-Pereira AL, Jordão CC, et al. (2025). Zerumbone enhances the photodynamic effect against biofilms of fluconazole-resistant Candida albicans clinical isolates. Journal of Dentistry, 155:105631. — PubMed
  10. Gorayb Pereira AL, Augusto Abreu Pereira C, Dias LM, Jorge JH, Pavarina AC (2025). Zerumbone disrupts mixed biofilms of Candida albicans and Streptococcus mutans on acrylic resin. Biofouling, 41(1):52–67. — PubMed
  11. Deepika, Singh A, Chaudhari AK, Das S, Dubey NK (2021). Zingiber zerumbet L. essential oil-based chitosan nanoemulsion as an efficient green preservative against fungi and aflatoxin B(1) contamination. Journal of Food Science, 86(1):149–160. — PubMed
  12. Huanbutta K, Rattanachitthawat N, Luangpraditkun K, et al. (2022). Development and Evaluation of Ethosomes Loaded with Zingiber zerumbet Linn Rhizome Extract for Antifungal Skin Infection in Deep Layer Skin. Pharmaceutics, 14(12). — PubMed
  13. Kader G, Nikkon F, Rashid MA, Yeasmin T (2011). Antimicrobial activities of the rhizome extract of Zingiber zerumbet Linn. Asian Pacific Journal of Tropical Biomedicine, 1(5):409–12. — PubMed

Back to Table of Contents

Connections

Back to Table of Contents